Corticosteroids in immunosuppression: partial fulfillment of a promise.
D000917:Antibody Formation / Q000187:drug effects; D001379:Azathioprine / Q000627:therapeutic use; D002462:Cell Membrane / Q000187:drug effects; D003520:Cyclophosphamide / Q000627:therapeutic use; D005938:Glucocorticoids / Q000494:pharmacology*; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007166:Immunosuppressive Agents; D016030:Kidney Transplantation; D007959:Lymphocyte Culture Test, Mixed; D008212:Lymphocyte Depletion; D008231:Lymphopenia / Q000139:chemically induced; D008775:Methylprednisolone / Q000627:therapeutic use; D009404:Nephrotic Syndrome / Q000188:drug therapy; D011241:Prednisone / Q000008:administration & dosage; D011956:Receptors, Cell Surface; D016038:Skin Transplantation; D013601:T-Lymphocytes / Q000276:immunology; D013950:Thymus Gland / Q000187:drug effects*; D014181:Transplantation Immunology / Q000187:drug effects; D014184:Transplantation, Homologous
D005938:Glucocorticoids; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007166:Immunosuppressive Agents; D011956:Receptors, Cell Surface; D003520:Cyclophosphamide; D001379:Azathioprine; D011241:Prednisone; D008775:Methylprednisolone